Total Payments
$2,044
2024 Payments
$569.77
Companies
21
Transactions
102
Medicare Patients
2,759
Medicare Billing
$337,229
Payment Breakdown by Category
Food & Beverage$1,886 (92.3%)
Education$158.01 (7.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,886 | 95 | 92.3% |
| Education | $158.01 | 7 | 7.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $748.62 | 42 | $0 (2024) |
| Lilly USA, LLC | $282.67 | 12 | $0 (2024) |
| PFIZER INC. | $129.96 | 9 | $0 (2022) |
| AbbVie Inc. | $126.78 | 5 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $115.44 | 7 | $0 (2024) |
| Coherus Biosciences Inc. | $108.65 | 4 | $0 (2024) |
| Astellas Pharma US Inc | $77.97 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $64.83 | 4 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $47.77 | 2 | $0 (2024) |
| Dexcom, Inc. | $46.74 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $569.77 | 21 | Novo Nordisk Inc ($141.71) |
| 2023 | $465.81 | 21 | Lilly USA, LLC ($123.52) |
| 2022 | $371.99 | 20 | Novo Nordisk Inc ($129.61) |
| 2021 | $298.10 | 18 | Novo Nordisk Inc ($215.72) |
| 2020 | $72.42 | 5 | PFIZER INC. ($37.99) |
| 2019 | $109.12 | 7 | Novo Nordisk Inc ($63.14) |
| 2018 | $70.95 | 4 | Novo Nordisk Inc ($34.20) |
| 2017 | $85.35 | 6 | Novo Nordisk Inc ($42.75) |
All Payment Transactions
102 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | Coherus Biosciences Inc. | LOQTORZI (Biological), Udenyca | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: Endocrinology | ||||||
| 10/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: Obesity | ||||||
| 10/16/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $77.97 | General |
| 10/03/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $30.27 | General |
| Category: DESMOID TUMORS | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 08/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Obesity | ||||||
| 07/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.10 | General |
| 06/22/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 06/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Obesity | ||||||
| 05/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Diabetes | ||||||
| 04/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Inflammation | ||||||
| 04/05/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Diabetes | ||||||
| 04/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Diabetes | ||||||
| 03/27/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $33.34 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 01/31/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $16.80 | General |
| Category: Medical Device | ||||||
| 01/30/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Diabetes | ||||||
| 01/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/15/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.31 | General |
| 10/20/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.58 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 711 | 1,150 | $168,873 | $89,372 |
| 2022 | 10 | 802 | 1,232 | $175,067 | $102,121 |
| 2021 | 7 | 694 | 1,132 | $143,279 | $90,697 |
| 2020 | 7 | 552 | 868 | $111,912 | $55,039 |
Total Patients
2,759
Total Services
4,382
Medicare Billing
$337,229
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 228 | 473 | $85,187 | $39,434 | 46.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 141 | 332 | $42,413 | $21,018 | 49.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 134 | 134 | $24,695 | $18,079 | 73.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 19 | 22 | $6,867 | $5,003 | 72.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 14 | 14 | $3,284 | $2,056 | 62.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 132 | 132 | $1,914 | $1,876 | 98.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,298 | $1,604 | 48.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 29 | 29 | $1,215 | $301.97 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 207 | 437 | $73,846 | $36,789 | 49.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 155 | 155 | $27,789 | $21,515 | 77.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 129 | 306 | $38,907 | $20,505 | 52.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 110 | 125 | $14,441 | $9,100 | 63.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 18 | 24 | $7,492 | $5,541 | 74.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 14 | 14 | $3,144 | $2,466 | 78.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 14 | 14 | $3,303 | $2,298 | 69.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $3,396 | $1,931 | 56.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 118 | 118 | $1,711 | $1,681 | 98.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 22 | 24 | $1,039 | $294.75 | 28.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 197 | 438 | $64,211 | $37,788 | 58.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 120 | 306 | $38,428 | $22,016 | 57.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 109 | 109 | $17,920 | $15,447 | 86.2% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 119 | 127 | $14,496 | $9,640 | 66.5% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 16 | 18 | $5,619 | $3,925 | 69.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 113 | 113 | $1,639 | $1,624 | 99.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 20 | 21 | $967.47 | $257.74 | 26.6% |
About Dr. David Saito, M.D
Dr. David Saito, M.D is a Internal Medicine healthcare provider based in Aiea, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457369514.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Saito, M.D has received a total of $2,044 in payments from pharmaceutical and medical device companies, with $569.77 received in 2024. These payments were reported across 102 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,886).
As a Medicare-enrolled provider, Saito has provided services to 2,759 Medicare beneficiaries, totaling 4,382 services with total Medicare billing of $337,229. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Aiea, HI
- Active Since 08/04/2006
- Last Updated 07/10/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1457369514
Products in Payments
- Ozempic (Drug) $261.24
- Rybelsus (Drug) $128.18
- Wegovy (Drug) $115.01
- RYBELSUS (Drug) $109.14
- TRULICITY (Drug) $105.50
- EMGALITY (Drug) $100.02
- Udenyca (Biological) $84.44
- MOUNJARO (Drug) $77.15
- FARXIGA (Drug) $68.05
- LORBRENA (Drug) $53.10
- DALVANCE (Drug) $49.72
- XARELTO (Drug) $47.77
- UBRELVY (Drug) $47.73
- Dexcom G6 Transmitter (Medical Supply) $46.74
- NURTEC ODT (Drug) $41.82
- LEQVIO (Drug) $38.97
- Saxenda (Drug) $37.52
- Vascepa (Drug) $33.98
- ELIQUIS (Drug) $31.75
- FOTIVDA (Drug) $31.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Aiea
Roy Ebisu, Md, MD
Internal Medicine — Payments: $18,765
Internal Medicine $18,765
Stephen Miyasato, Md, MD
Internal Medicine — Payments: $18,084
Internal Medicine $18,084
Dr. Francis Buto, M.d, M.D
Internal Medicine — Payments: $14,868
Internal Medicine $14,868
Dr. Alan Oki, Md, MD
Internal Medicine — Payments: $14,573
Internal Medicine $14,573
Mark Nishihara, M.d, M.D
Internal Medicine — Payments: $14,206
Internal Medicine $14,206
Dr. Malissa Iida-Takashima, Md, MD
Internal Medicine — Payments: $13,761
Internal Medicine $13,761